Alastair MacLennan

Research Interests

Alternative Medicine Epigenetics Genomics Neuroscience, Behaviour and Brain Health Musculoskeletal Health Early Origins of Health Child and Adolescent Health

Alastair MacLennan

School of Medicine

College of Health

Emeritus Professor Alastair MacLennan, AO, MB ChB, MD, FRCOG, FRANZCOG is Head of the Australian Collaborative Cerebral Palsy Research Group at the Robinson Research Institute, The University of Adelaide. His research group specifically studies causation and the genetic pathways to cerebral palsy. He was the third Professorial Head of Obstetrics and Gynaecology. He is also Vice President of Friends of Science in Medicine.

Research Interests

My main research interests are now in the causes of cerebral palsy and in particular the genetic and epigenetic causes.

i also continue my interest in having a quality evidence base for all health interventions both traditional and alternative. Alternative therapies currently are poorly regulated, often have associated unproven claims for safety and efficacy and are often driven by the vested interests of industry. 

Date Position Institution name
2012 - ongoing Emeritus Professor The Robinson Resaerch Institute
2012 - ongoing Honorary Vice President Friends Of Science in Medicine
2006 - 2012 Professor and Head of the Discipline of Obstetrics and Gynaecology University of Adelaide, Adelaide

Date Type Title Institution Name Country Amount
2011 Award Professor Derek Frewin Excellence in student teaching Award The University of Adelaide - -
2011 Honour Officer in the Order of Australia (AO) Australian Government Australia -
2009 Award South Australian Government’s Science Excellence Award for Public Good. South Australian Government Australia 10,000

Date Institution name Country Title
University of Glasgow, RCOG London, RANZCOG Melbourne United Kingdom OA, MB ChB, MD, FRCOG, FRANZCOG

Date Title Institution Country
Glasgow, Chicago, Oxford, San Fransisco, Adelaide Universities of the above Scotland, USA, England and Australia

Year Citation
2025 Berry, J. G., Taranath, A., Goetti, R., Farrar, M. A., Fiori, S., Pham, H. -D., . . . van Eyk, C. L. (2025). Genetic diagnostic yield by MRI pattern in children with cerebral palsy: a population-based study.. EBioMedicine, 122, 106013.
DOI
2024 Wang, Y., Xu, Y., Zhou, C., Cheng, Y., Qiao, N., Shang, Q., . . . Xing, Q. (2024). Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy.. Nat Med, 30(5), 1395-1405.
DOI Scopus21 WoS18 Europe PMC14
2024 Sandran, N. G., Fornarino, D. L., Corbett, M. A., Kroes, T., Gardner, A. E., MacLennan, A. H., . . . van Eyk, C. L. (2024). Application of multiple mosaic callers improves post-zygotic mutation detection from exome sequencing data. Genetics in Medicine, 26(10), 101220-1-101220-14.
DOI
2023 van Eyk, C., MacLennan, S. C., & MacLennan, A. H. (2023). All Patients With a Cerebral Palsy Diagnosis Merit Genomic Sequencing. JAMA Pediatrics, 177(5), 455-456.
DOI Scopus14 WoS14 Europe PMC12
2022 Kayumi, S., Pérez-Jurado, L. A., Palomares, M., Rangu, S., Sheppard, S. E., Chung, W. K., . . . Corbett, M. A. (2022). Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants. Genetics in Medicine, 24(11), 2351-2366.
DOI Scopus35 WoS37 Europe PMC32
2022 Martin, M., Hill, C., Bewley, S., MacLennan, A. H., & Braillon, A. (2022). Transgenerational adverse effects of valproate? A patient report from 90 affected families. Birth Defects Research, 114(1), 13-16.
DOI Scopus28 Europe PMC22
2021 van Eyk, C. L., Webber, D. L., Minoche, A. E., Pérez-Jurado, L. A., Corbett, M. A., Gardner, A. E., . . . Gecz, J. (2021). Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing. npj Genomic Medicine, 6(1), 74-1-74-11.
DOI Scopus28 WoS29 Europe PMC27
2021 Richard, E. M., Bakhtiari, S., Marsh, A. P. L., Kaiyrzhanov, R., Wagner, M., Shetty, S., . . . Kruer, M. C. (2021). Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. American Journal of Human Genetics, 108(10), 2006-2016.
DOI Scopus19 WoS16 Europe PMC18
2021 Jin, S. C., Lewis, S. A., Bakhtiari, S., Zeng, X., Sierant, M. C., Shetty, S., . . . Kruer, M. C. (2021). Author Correction: Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.. Nat Genet, 53(3), 412.
DOI Scopus2 WoS1 Europe PMC1
2021 Maclennan, A. H. (2021). All cases of cerebral palsy warrant genomic screening. Developmental Medicine and Child Neurology, 63(12), 1369.
DOI Scopus1 WoS1 Europe PMC1
2020 Pham, R., Mol, B. W., Gecz, J., MacLennan, A. H., MacLennan, S. C., Corbett, M. A., . . . Berry, J. G. (2020). Definition and diagnosis of cerebral palsy in genetic studies: a systematic review. Developmental Medicine and Child Neurology, 62(9), 1024-1030.
DOI Scopus31 WoS31 Europe PMC28
2020 Jin, S. C., Lewis, S. A., Bakhtiari, S., Zeng, X., Sierant, M. C., Shetty, S., . . . Kruer, M. C. (2020). Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics, 52(10), 1046-1056.
DOI Scopus145 WoS127 Europe PMC116
2019 Helbig, K. L., Lauerer, R. J., Bahr, J. C., Souza, I. A., Myers, C. T., Uysal, B., . . . Jacobsen, J. C. (2019). Erratum: De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (The American Journal of Human Genetics (2018) 103(5) (666–678), (S0002929718303173), (10.1016/j.ajhg.2018.09.006)). American Journal of Human Genetics, 104(3), 562.
DOI Scopus9 WoS6 Europe PMC7
2019 MacLennan, A. H., Lewis, S., Moreno-De-Luca, A., Fahey, M., Leventer, R. J., McIntyre, S., . . . Gecz, J. (2019). Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy. Journal of Child Neurology, 34(8), 472-476.
DOI Scopus106 WoS90 Europe PMC79
2019 Corbett, M. A., van Eyk, C. L., Webber, D. L., Bent, S. J., Newman, M., Harper, K., . . . Gecz, J. (2019). Author Correction: Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy (npj Genomic Medicine, (2018), 3, 1, (33), 10.1038/s41525-018-0073-4). Npj Genomic Medicine, 4(1), 1 page.
DOI WoS2 Europe PMC3
2019 Braillon, A., Maclennan, A., Marron, L., & Dervaux, A. (2019). Teaching midwives to poke with needles on non-existing meridians. Women and Birth, 32(2), e284-e285.
DOI Scopus3 Europe PMC3
2019 van Eyk, C. L., Corbett, M. A., Frank, M. S. B., Webber, D. L., Newman, M., Berry, J. G., . . . Gecz, J. (2019). Targeted resequencing identifies genes with recurrent variation in cerebral palsy. npj Genomic Medicine, 4(1), 27-1-27-11.
DOI Scopus29 WoS24 Europe PMC23
2018 Helbig, K. L., Lauerer, R. J., Bahr, J. C., Souza, I. A., Myers, C. T., Uysal, B., . . . Zamponi, G. W. (2018). De novo pathogenic variants in CACNA1E cause developmental and epileptic encephalopathy with contractures, macrocephaly, and dyskinesias. American Journal of Human Genetics, 103(5), 666-678.
DOI Scopus103 WoS93 Europe PMC82
2018 Corbett, M. A., van Eyk, C. L., Webber, D. L., Bent, S. J., Newman, M., Harper, K., . . . Gecz, J. (2018). Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy. npj Genomic Medicine, 3(1), 33-1-33-9.
DOI Scopus43 WoS37 Europe PMC31
2018 MacLennan, A. H., Kruer, M. C., Baynam, G., Moreno-De-Luca, A., Wilson, Y. A., Zhu, C., . . . Gecz, J. (2018). Cerebral palsy and genomics: an international consortium. Developmental Medicine and Child Neurology, 60(2), 209-210.
DOI Scopus22 WoS19 Europe PMC16
2018 Van Eyk, C., Corbett, M., Gardner, A., Van Bon, B., Broadbent, J., Harper, K., . . . Gecz, J. (2018). Analysis of 182 cerebral palsy transcriptomes points to dysregulation of trophic signalling pathways and overlap with autism. Translational Psychiatry, 8(1), 88 -1-88 -10.
DOI Scopus26 WoS26 Europe PMC23
2018 MacLennan, A., Gecz, J., & Pérez-Jurado, L. (2018). A genomic cause of cerebral palsy should not change the clinical classification. Annals of Clinical and Translational Neurology, 5(8), 1011.
DOI Scopus6 WoS5 Europe PMC5
2017 Fahey, M., Maclennan, A., Kretzschmar, D., Gecz, J., & Kruer, M. (2017). The genetic basis of cerebral palsy. Developmental Medicine and Child Neurology, 59(5), 462-469.
DOI Scopus169 WoS133 Europe PMC113
2016 Maclennan, A. H., Thompson, S. C., & Gecz, J. (2016). Reply. American Journal of Obstetrics and Gynecology, 214(5), 671.
DOI
2015 McMichael, G., Bainbridge, M., Haan, E., Corbett, M., Gardner, A., Thompson, S., . . . MacLennan, A. (2015). Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Molecular Psychiatry, 20(2), 176-182.
DOI Scopus194 WoS161 Europe PMC142
2015 Maclennan, A. (2015). Letters to the editor. Menopause, 22(3), 361.
DOI
2015 MacLennan, A., Thompson, S., & Gecz, J. (2015). Cerebral palsy: causes, pathways, and the role of genetic variants. American Journal of Obstetrics and Gynecology, 213(6), 779-788.
DOI Scopus338 WoS237 Europe PMC196
2013 O'Callaghan, M., & MacLennan, A. (2013). Cesarean delivery and cerebral palsy: A systematic review and meta-analysis. Obstetrics and Gynecology, 122(6), 1169-1175.
DOI Scopus46 WoS38 Europe PMC32
2013 McMichael, G., Haan, E., Gardner, A., Yap, T., Thompson, S., Ouvrier, R., . . . MacLennan, A. (2013). NKX2-1 mutation in a family diagnosed with ataxic dyskinetic cerebral palsy. European Journal of Medical Genetics, 56(9), 506-509.
DOI Scopus16 WoS11 Europe PMC12
2013 O'Callaghan, M., MacLennan, A., McMichael, G., Haan, E., & Dekker, G. (2013). Single-nucleotide polymorphism associations with preterm delivery: a case-control replication study and meta-analysis. Pediatric Research, 74(4), 433-438.
DOI Scopus9 WoS7 Europe PMC5
2013 McMichael, G., Girirajan, S., Moreno-De-Luca, A., Gecz, J., Shard, C., Nguyen, L., . . . MacLennan, A. (2013). Rare copy number variation in cerebral palsy. European Journal of Human Genetics, 22(1), 40-45.
DOI Scopus68 WoS57 Europe PMC59
2013 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2013). Genetic and clinical contributions to cerebral palsy: A multi-variable analysis. Journal of Paediatrics and Child Health, 49(7), 575-581.
DOI Scopus20 WoS10 Europe PMC10
2013 Hirata, H., McMichael, G., Haan, E., MacLennan, A., Yap, T., Nguyen, L., . . . Gecz, J. (2013). ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticity. American Journal of Human Genetics, 92(5), 681-695.
DOI Scopus73 WoS70 Europe PMC67
2013 Avery, J., Stocks, N., Duggan, P., Braunack-Mayer, A., Taylor, A., Goldney, R., & MacLennan, A. (2013). Identifying the quality of life effects of urinary incontinence with depression in an Australian population. BMC Urology, 13(11), 2-9.
DOI Scopus46 WoS42 Europe PMC29
2013 O'Callaghan, M., & MacLennan, A. (2013). Brain damage and maternal medication. American Journal of Obstetrics and Gynecology, 208(2), 160-161.
DOI
2012 McMichael, G., MacLennan, A., Gibson, C., Alvino, E., Goldwater, P., Haan, E., & Dekker, G. (2012). Cytomegalovirus and Epstein–Barr virus may be associated with some cases of cerebral palsy. The Journal of Maternal - Fetal & Neonatal Medicine, 25(10), 2078-2081.
DOI Scopus18 WoS10 Europe PMC10
2012 Purbrick, B., Stranks, K., Sum, C., & MacLennan, A. (2012). Future long-term trials of postmenopausal hormone replacement therapy: what is possible and what is the optimal protocol and regimen?. Climacteric, 15(3), 288-293.
DOI Scopus5 WoS3 Europe PMC3
2012 Burger, H., MacLennan, A., Huang, K., & Castelo-Branco, C. (2012). Evidence-based assessment of the impact of the WHI on women's health. Climacteric, 15(3), 281-287.
DOI Scopus56 WoS42 Europe PMC33
2012 Pines, A., Sturdee, D., & MacLennan, A. (2012). Quality of life and the role of menopausal hormone therapy. Climacteric, 15(3), 213-216.
DOI Scopus25 WoS18 Europe PMC14
2012 MacLennan, A., & Morrison, R. (2012). Tertiary education institutions should not offer pseudoscientific medical courses: standing up for science. Medical Journal of Australia, 196(4), 225-226.
DOI Scopus31 WoS25 Europe PMC15
2012 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2012). Fetal and maternal candidate single nucleotide polymorphism associations with Cerebral Palsy: a case-control study. Pediatrics, 129(2), E414-E423.
DOI Scopus33 WoS23 Europe PMC23
2012 MacLennan, A., & MacLennan, A. (2012). Surgical menopause and early mortality in the California Teachers Study. Climacteric, 15(2), 203-204.
DOI
2011 MacLennan, A. (2011). A 'no-fault' cerebral palsy pension scheme would benefit all Australians. Australian & New Zealand Journal of Obstetrics & Gynaecology, 51(6), 479-484.
DOI Scopus11 WoS9 Europe PMC8
2011 MacLennan, A., & Morris, D. (2011). Multiple choice in the management of the menopause. Climacteric, 14(6), 697-702.
DOI
2011 Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., . . . Warren, M. (2011). Menopausal hot flushes and night sweats: where are we now?. Climacteric, 14(5), 515-528.
DOI Scopus174 WoS143 Europe PMC107
2011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). Epidemiologic associations with cerebral palsy. Obstetrics and Gynecology, 118(3), 576-582.
DOI Scopus99 WoS89 Europe PMC71
2011 McMichael, G., Highet, A., Gibson, C., Goldwater, P., O'Callaghan, M., Alvino, E., & MacLennan, A. (2011). Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques, 22(1), 5-9.
Scopus8 Europe PMC4
2011 MacLennan, A. (2011). HRT in difficult circumstances: are there any absolute contraindications?. Climacteric, 14(4), 409-417.
DOI Scopus22 WoS16 Europe PMC11
2011 Sturdee, D., Pines, A., Archer, D., Baber, R., Barlow, D., Birkhauser, M., . . . Stevenson, J. (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320.
DOI
2011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). The Australian cerebral palsy research study - Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. Journal of Paediatrics and Child Health, 47(3), 99-110.
DOI Scopus12 WoS10 Europe PMC8
2011 Wong, L., & MacLennan, A. (2011). Gathering the evidence: Cord gases and placental histology for births with low Apgar scores. Australian & New Zealand Journal of Obstetrics & Gynaecology, 51(1), 17-21.
DOI Scopus20 WoS12 Europe PMC14
2011 Gibson, C., MacLennan, A., Haan, E., Priest, K., & Dekker, G. (2011). Fetal MBL2 haplotypes combined with viral exposure are associated with adverse pregnancy outcomes. The Journal of Maternal - Fetal & Neonatal Medicine, 24(6), 847-854.
DOI Scopus11 WoS11 Europe PMC9
2010 MacLennan, A. (2010). The ascent of woman from Queen Adelaide to Queen Camilla. Australian & New Zealand Journal of Obstetrics & Gynaecology, 50(3), 211-215.
DOI
2010 Maclennan, A. (2010). The Causes of Cerebral Palsy in IVF and ART. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 50, 31-32.
2010 Maclennan, A., Sturdee, D., Fenton, A., & Panay, N. (2010). Editorial: Ghost writers, vested interest and funding disclosures. Climacteric, 13(4), 301-302.
DOI Scopus2 Europe PMC1
2009 Welton, A. J., Vickers, M. R., Kim, J., Ford, D., Lawton, B. A., MacLennan, A. H., . . . Meade, T. W. (2009). Health-related quality of life after combined Hormone-Replacement therapy: Randomized controlled trial: Women's international study of long duration estrogen after the menopause. Obstetrical and Gynecological Survey, 64(4), 238-240.
DOI Scopus3
2009 McMichael, G., Gibson, C., O'Callaghan, M., Goldwater, P., Dekker, G., Haan, E., & MacLennan, A. (2009). DNA from Buccal Swabs Suitable for High-Throughput SNP Multiplex Analysis. Journal of Biomolecular Techniques, 20(5), 232-235.
Scopus33 Europe PMC25
2009 MacLennan, A., & Baber, R. (2009). Hormone therapy use and risk of ovarian cancer. Jama-journal of the American Medical Association, 302(20), 2203.
DOI Scopus4 WoS3
2009 MacLennan, A. (2009). Evidence-based review of therapies at the menopause. International Journal of Evidence-based Healthcare, 7(2), 112-123.
DOI Scopus38 WoS30 Europe PMC24
2009 O'Callaghan, M., MacLennan, A., Haan, E., & Dekker, G. (2009). The genomic basis of cerebral palsy: A HuGE systematic literature review. Human Genetics, 126(1), 149-172.
DOI Scopus51 WoS39 Europe PMC38
2009 Djukic, M., Gibson, C., MacLennan, A., Goldwater, P., Haan, E., McMichael, G., . . . Casey, G. (2009). Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 49(3), 247-253.
DOI Scopus30 WoS28 Europe PMC26
2009 MacLennan, A., Gill, T., Broadbent, J., & Taylor, A. (2009). Continuing decline in hormone therapy use: population trends over 17 years. Climacteric, 12(2), 122-130.
DOI Scopus34 WoS35 Europe PMC28
2009 MacLennan, A. H. (2009). Hormone replacement therapy: A 2008 perspective. Poloznictwo Ginekologia I Medycyna Rozrodu, 3(3), 183-190.
2009 Gibson, C. S., MacLennan, A. H., Dekker, G. A., Goldwater, P. N., Sullivan, T. R., Munroe, D. J., . . . Nelson, K. B. (2009). Candidate genes and cerebral palsy: A population-based study. Obstetrical and Gynecological Survey, 64(3), 154-155.
DOI
2008 MacLennan, A. H., & Sturdee, D. W. (2008). The use and abuse of screening tests around menopause. Medicine Today, 9(3), 15-17.
2008 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2008). Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. American Journal of Obstetrics and Gynecology, 198(5), 509.e1-509.e8.
DOI Scopus20 WoS18 Europe PMC13
2008 Cummings, S., Ettinger, B., Delmas, P., Kenemans, P., Stathopoulos, V., Verweij, P., . . . MacLennan, A. (2008). The effects of tibolone in older postmenopausal women. New England Journal of Medicine, 359(7), 697-708.
DOI
2008 MacLennan, A. (2008). Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynecology and Reproductive Medicine, 19(1), 13-18.
DOI Scopus7
2008 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2008). Mannose binding lectin haplotypes are associated with cerebral palsy. American Journal of Obstetrics and Gynecology, 197(6 Suppl 1), S14.
DOI WoS1
2008 MacLennan, A. (2008). Hormone replacement therapy reversal, revision and redemption. Medicine Today, 9(3), 18-28.
2008 Gibson, C., MacLennan, A., Goldwater, P., & Dekker, G. (2008). The antenatal causes of cerebral palsy - Genetic and viral associations. Fetal and Maternal Medicine Review, 19(3), 181-201.
DOI Scopus1
2008 Gibson, C., MacLennan, A., Dekker, G., Goldwater, P., Sullivan, T., Munroe, D., . . . Nelson, K. (2008). Candidate Genes and Cerebral Palsy: A Population-Based Study. Pediatrics, 122(5), 1079-1085.
DOI Scopus58 WoS47 Europe PMC43
2008 McMichael, G., Gibson, C., Goldwater, P., Haan, E., Priest, K., Dekker, G., & MacLennan, A. (2008). Association between apolipoprotein E genotype and cerebral palsy is not confirmed in a caucasian population. Human Genetics, 124(4), 411-416.
DOI Scopus33 WoS28 Europe PMC28
2008 Welton, A., Vickers, M., Kim, J., Ford, D., Lawton, B., MacLennan, A., . . . Meade, T. (2008). Health related quality of life after combined hormone replacement therapy: randomised controlled trial. British Medical Journal, 337(7669), 550-553.
DOI Scopus173 WoS127 Europe PMC103
2008 Schneider, H., MacLennan, A., & Feeny, D. (2008). Assessment of health-related quality of life in menopause and aging. Climacteric, 11(2), 93-107.
DOI Scopus25 WoS23 Europe PMC17
2008 Paine, B., Stocks, N., & MacLennan, A. (2008). Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM. Trials, 9(1), WWW 1-WWW 8.
DOI Scopus10 WoS10 Europe PMC8
2008 Gibson, C., Goldwater, P., MacLennan, A., Haan, E., Priest, K., & Dekker, G. (2008). Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG, 115(4), 492-500.
DOI Scopus59 WoS51 Europe PMC47
2007 Vickers, M., Martin, J., Meade, T., Wilkes, H., Ford, D., Walgrove, A., . . . MacLennan, A. (2007). The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Women's Health, 7(2), 1-17.
DOI
2007 Albertazzi, P., Barlow, D., Berry, E., Birkhauser, M., Bocker, W., Brincat, M., . . . Sturdee, D. (2007). IMS Updated recommendations on postmenopausal hormone therapy. Climacteric, 2007(10), 181-194.
DOI
2007 MacLennan, A., & Sturdee, D. (2007). Time for evidence-based labelling of over-the-counter medicines. Climacteric, 10(3), 179-180.
DOI Scopus2 Europe PMC1
2007 MacLennan, A. (2007). HRT: a reappraisal of the risks and benefits. Medical Journal of Australia, 186(12), 643-646.
DOI Scopus19 WoS16 Europe PMC12
2007 Gibson, C., MacLennan, A., Dekker, G., Goldwater, P., Dambrosia, J., Munroe, D., . . . Nelson, K. (2007). Genetic polymorphisms and spontaneous preterm birth. Obstetrics and Gynecology, 109(2 Part 1), 384-391.
DOI Scopus62 WoS53 Europe PMC48
2007 Vickers, M., MacLennan, A., Lawton, B., Ford, D., Martin, J., Meredith, S., . . . Meade, T. (2007). Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. British Medical Journal, 335(239), 1-12.
DOI Scopus220 WoS184 Europe PMC151
2007 Sturdee, D. W., & MacLennan, A. H. (2007). A decade of swings and arrows. Climacteric, 10(6), 443-445.
DOI Scopus1 Europe PMC1
2007 Sturdee, D. W., & MacLennan, A. H. (2007). The weight problem. Climacteric, 10(2), 83-84.
DOI Scopus1
2007 MacLennan, A. H., & Sturdee, D. W. (2007). The impact of a decade of Climacteric. Climacteric, 10(5), 355.
DOI
2007 Pines, A., Sturdee, D. W., MacLennan, A. H., Schneider, H. P. G., Burger, H., & Fenton, A. (2007). The heart of the WHI study: Time for hormone therapy policies to be revised. Climacteric, 10(4), 267-269.
DOI Scopus24 Europe PMC18
2007 MacLennan, A. H., & Sturdee, D. W. (2007). Long-term trials of HRT for cardioprotection - Is this as good as it gets?. Climacteric, 10(1), 1-4.
DOI Scopus6 Europe PMC7
2006 Gibson, C. S., MacLennan, A. H., Goldwater, P. N., Haan, E. A., Priest, K., & Dekker, G. A. (2006). Neurotrophic viruses and cerebral palsy: Population based case - Control study: Commentary. Obstetrical and Gynecological Survey, 61(6), 359-360.
DOI
2006 MacLennan, A. (2006). Cerebral palsy and obstetric intervention. MedicSA, 19(10), 28-29.
2006 MacLennan, A., & Sturdee, D. (2006). Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?. Climacteric, 9(5), 321-322.
DOI Scopus4 Europe PMC3
2006 Sturdee, D., & MacLennan, A. (2006). Reducing the problems of the progestogen. Climacteric, 9(4), 241-243.
DOI Scopus3 Europe PMC4
2006 O'Neill, S., MacLennan, A., Bass, S., Diamond, T., Ebeling, P., Findlay, D., . . . Fiatarone-Singh, M. (2006). Wytyczne postępowania z osteoporozą omenopauzalną dla lekarzy rodzinnych. Lekarz Rodzinny, 4(104), 444-455.
2006 MacLennan, A., Hankins, G., & Speer, M. (2006). Only an expert witness can prevent cerebral palsy!. O & G, 8(1), 28-30.
2006 MacLennan, A. (2006). A 41-year-old woman with premature menopause. Medicine Today, 7(2), 62-64.
2006 MacLennan, A., & Sturdee, D. (2006). The 'bioidentical/bioequivalent' hormone scam. Climacteric, 9(1), 1-3.
DOI Scopus17 Europe PMC18
2006 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2006). Neurotropic viruses and cerebral palsy: population based case-control study. British Medical Journal, 332(7533), 76-79.
DOI Scopus71 WoS56 Europe PMC45
2006 Sturdee, D., & MacLennan, A. (2006). Not all placebos are equally pleasing. Climacteric, 9(6), 401-403.
DOI Scopus4 WoS3 Europe PMC3
2006 MacLennan, A., & Sturdee, D. (2006). The use and abuse of screening tests around menopause. Climacteric, 9(3), 153-155.
DOI Scopus2 WoS1 Europe PMC1
2006 Sturdee, D., & MacLennan, A. (2006). The pendulum swings back; estrogen is now beneficial if started at the right time. Climacteric, 9(2), 73-74.
DOI Scopus12 WoS9 Europe PMC9
2006 MacLennan, A., Nelson, K., Hankins, G., & Speer, M. (2006). Cerebral palsy litigation - Reply. Jama-journal of the American Medical Association, 295(6), 626.
DOI WoS1
2006 Hankins, G., MacLennan, A., Speer, M., Strunk, A., & Nelson, K. (2006). Obstetric litigation is asphyxiating our maternity services. Obstetrics and Gynecology, 107(6), 1382-1385.
DOI Scopus36 WoS34 Europe PMC28
2006 Conlin, M., MacLennan, A., & Broadbent, J. (2006). Inadequate compliance with periconceptional folic acid supplementation in South Australia. Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(6), 528-533.
DOI Scopus28 WoS27 Europe PMC23
2006 Strijbis, E., Oudman, I., van Essen, P., & MacLennan, A. (2006). Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstetrics and Gynecology, 107(6), 1357-1365.
DOI Scopus103 WoS63 Europe PMC51
2006 Gibson, C., MacLennan, A., Janssen, N., Kist, W., Hague, W., Haan, E., . . . Dekker, G. (2006). Associations between fetal inherited thrombophilia and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology, 194(4), 947e1-947e10.
DOI Scopus38 WoS26 Europe PMC19
2006 MacLennan, A., Myers, S., & Taylor, A. (2006). The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Medical Journal of Australia, 184(1), 27-31.
DOI Scopus379 WoS305 Europe PMC212
2006 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., Dekker, G., . . . Morton, M. (2006). The association between inherited cytokine polymorphisms and cerebral palsy. American Journal of Obstetrics and Gynecology, 194(3), 674e1-674e11.
DOI Scopus61 WoS39 Europe PMC37
2006 Taylor, A., MacLennan, A., & Avery, J. (2006). Postmenopausal hormone therapy: Who now takes it and do they differ from non-users?. Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(2), 128-135.
DOI Scopus17 WoS16 Europe PMC13
2006 MacLennan, A., Henderson, V., Paine, B., Mathias, J., Ramsay, E., Ryan, P., . . . Taylor, A. (2006). Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause-The Journal of the North American Menopause Society, 13(1), 28-36.
DOI Scopus150 WoS129 Europe PMC110
2005 Sturdee, D., & MacLennan, A. (2005). How low can you go?. Climacteric, 8(4), 305-306.
DOI
2005 Norman, R., & MacLennan, A. (2005). Current status of hormone therapy and breast cancer. Human Reproduction Update, 11(6), 541-543.
DOI Scopus12 WoS9 Europe PMC6
2005 MacLennan, A., Nelson, K., Hankins, G., & Speer, M. (2005). Who will deliver our grandchildren? Implications of cerebral palsy litigation. Jama-journal of the American Medical Association, 294(13), 1688-1690.
DOI Scopus95 WoS75 Europe PMC55
2005 Gibson, C., MacLennan, A., Hague, W., Haan, E., Priest, K., Chan, A., & Dekker, G. (2005). Associations between inherited thrombophilias, gestational age, and cerebral palsy. American Journal of Obstetrics and Gynecology, 193(4), 1437.e1-1437.e12.
DOI Scopus61 WoS43 Europe PMC35
2005 Gibson, C., MacLennan, A., Rudzki, Z., Hague, W., Haan, E., Sharpe, P., . . . Khong, T. (2005). The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology, 37(2), 160-163.
DOI Scopus27 WoS24 Europe PMC20
2005 Sturdee, D., & MacLennan, A. (2005). Prevention of osteoporosis is still a valid aim for hormone therapy. Climacteric, 8(2), 97-98.
DOI Scopus9 Europe PMC4
2005 MacLennan, A., & Sturdee, D. (2005). Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies. Climacteric, 8(1), 1-2.
DOI Scopus6 Europe PMC8
2005 MacLennan, A. H., & Sturdee, D. W. (2005). Climacteric - The Journal of Adult Women's Health & Medicine. Climacteric, 8(3), 201-202.
DOI
2004 MacLennan, A., & Sturdee, D. W. (2004). Erratum: WHI, WHI, WHI? (Climacteric (2004) 7 (221-224)). Climacteric, 7(4).
2004 Sturdee, D., & MacLennan, A. (2004). Evolution and revolution at the menopause. Climacteric, 7(4), 325-326.
DOI Scopus2 Europe PMC2
2004 MacLennan, A., & Sturdee, D. (2004). WHI, WHI, WHI?. Climacteric, 7(3), 221-224.
DOI Scopus5 Europe PMC6
2004 MacLennan, A., Broadbent, J., Lester, S., & Moore, V. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes (review). The Cochrane Database of Systematic Reviews, 4(CD002978), 1-106.
DOI Scopus575 WoS122 Europe PMC192
2004 MacLennan, A., & Sturdee, D. (2004). Publishing the results of the estrogen-only arm of WHI. Climacteric, 7(2), 117-119.
DOI Scopus2 Europe PMC1
2004 Sturdee, D., & MacLennan, A. (2004). Should epidemiology, the media and quangos determine clinical practice?. Climacteric, 7(1), 1-2.
DOI Scopus12 Europe PMC10
2004 MacLennan, A., & Sturdee, D. (2004). WHI WHI WHI? Clarifying the interpretations of data from the Women's Health Initiative trial. O & G, 6(4), 298-300.
2004 O'Neill, S., MacLennan, A., Diamond, T., Ebeling, P., Findlay, D., Flicker, L., . . . Fiatarone-Singh, M. (2004). Guidelines for the management of postmenopausal osteoporosis for GPs. Australian Family Physician, 33(11), 910-919.
Scopus36 Europe PMC20
2004 MacLennan, A., & Robinson, J. (2004). Cerebral palsy and clinical negligence litigation: a cohort study. BJOG, 111(1), 92-93.
DOI Scopus5 WoS4 Europe PMC3
2004 Avery, J., Gill, T., MacLennan, A., Chittleborough, C., Grant, J., & Taylor, A. (2004). The impact of incontinence on health-related quality of life in a South Australian population sample. Australian Health Review, 28(2), 173-179.
DOI Scopus23 WoS21 Europe PMC16
2004 MacLennan, A. (2004). The trials and tribulations of long-term postmenopausal hormone therapy. Obstetrical & Gynecological Survey, 59(2), 65-67.
DOI Scopus1 WoS2
2004 Paine, B., Stocks, N., Ramsay, E., Ryan, P., & MacLennan, A. (2004). Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants. Climacteric, 7(2), 143-152.
DOI Scopus11 WoS9 Europe PMC6
2004 MacLennan, A., Taylor, A., & Wilson, D. (2004). Hormone therapy use after the Women's Health Initiative. Climacteric, 7(2), 138-142.
DOI Scopus56 WoS49 Europe PMC40
2003 MacLennan, A., Taylor, A., Wilson, D., & Wilson, D. (2003). The prevalence of pelvic floor disorders and their relationship to gender, age and mode of delivery - reply. BJOG, 110(1), 88-89.
DOI WoS2 Europe PMC2
2003 Gibson, C., MacLennan, A., Goldwater, P., & Dekker, G. (2003). Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstetrical & Gynecological Survey, 58(3), 209-220.
DOI Scopus56 WoS34 Europe PMC26
2003 MacLennan, A. (2003). Hormone replacement therapy: where to now?. Australian Prescriber, 26(1), 8-10.
DOI Scopus1
2003 MacLennan, A., & Sturdee, D. (2003). Time for new long-term trials of postmenopausal hormone therapies!. Climacteric, 6(4), 265-267.
DOI Scopus4 Europe PMC1
2003 Sturdee, D., & MacLennan, A. (2003). Is combined estrogen/progestogen hormone therapy worth the risk?. Climacteric, 6(3), 177-179.
DOI Scopus2 Europe PMC1
2003 MacLennan, A., & Sturdee, D. (2003). Is hormone therapy still an option for the management of osteoporosis?. Climacteric, 6(2), 89-91.
DOI Scopus5 Europe PMC2
2003 Sturdee, D. W., & MacLennan, A. (2003). HT or HRT, that is the question?. Climacteric, 6(1), 1.
DOI Scopus10 Europe PMC8
2002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners.. Australian family physician, 31(10), 921-928.
Scopus8
2002 Homer, C., Eckert, K., Turnbull, D., & MacLennan, A. (2002). Immersion in water during first stage of labor [2] (multiple letters). Birth, 29(1), 76-77.
DOI
2002 MacLennan, A. H., Lawton, B., Baber, R. J., Baum, M., & Dixon, J. M. (2002). Hormone replacement therapy and the breast [6] (multiple letters). British Medical Journal, 324(7342), 915-916.
Scopus1
2002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners. Australian Family Physician, 31(10), 921-928.
Scopus9 Europe PMC4
2002 Sturdee, D., & MacLennan, A. (2002). Primum non nocere. Climacteric, 5(3), 209-210.
DOI Scopus4 Europe PMC2
2002 MacLennan, A. (2002). A scent of a woman. Climacteric, 5(2), 105-106.
DOI
2002 MacLennan, A., & Spencer, M. (2002). Who will deliver the next generation of Australians?. O & G, 4(3), 208-209.
2002 Eckert, K., Turnbull, D., & MacLennan, A. (2002). Immersion in water during first stage of labor - Reply. Birth-issues in Perinatal Care, 29(1), 77.
DOI
2002 MacLennan, A., & Sturdee, D. (2002). The end of WISDOM. Climacteric, 5(4), 313-316.
DOI Scopus19 WoS13 Europe PMC13
2002 MacLennan, A., Lawton, B., & Baber, R. (2002). Hormone replacement therapy and the breast - Studies must determine the evidence. British Medical Journal, 324(7342), 915-916.
DOI Scopus4 WoS4 Europe PMC3
2002 MacLennan, A., Wilson, D., & Taylor, A. (2002). Hormone replacement therapy use over a decade in an Australian population. Climacteric, 5(4), 351-356.
DOI Scopus18 WoS14 Europe PMC11
2002 Hepworth, J., Paine, B., Miles, H., Marley, J., & MacLennan, A. (2002). The willingness of women to participate in a long-term trial of hormone replacement therapy: a qualitative study using focus groups. Psychology, Health & Medicine, 7(4), 469-476.
DOI Scopus8
2002 Stapleton, D., MacLennan, A., & Kristiansson, P. (2002). The prevalence of recalled low back pain during and after pregnancy: a South Australian population survey. Australian & New Zealand Journal of Obstetrics & Gynaecology, 42(5), 482-485.
DOI Scopus73 WoS52 Europe PMC45
2002 MacLennan, A., Wilson, D., & Taylor, A. (2002). The escalating cost and prevalence of alternative medicine. Preventive Medicine, 35(2), 166-173.
DOI Scopus440 WoS335 Europe PMC266
2002 MacLennan, A., & Spencer, M. (2002). Projections of Australian obstetricians ceasing practice and the reasons. Medical Journal of Australia, 176(9), 425-428.
DOI Scopus29 WoS29 Europe PMC19
2001 Spencer, M., & MacLennan, A. (2001). Reply from the authors. Australian & New Zealand Journal of Obstetrics & Gynaecology, 41(3), 355.
DOI WoS1
2001 MacLennan, A. (2001). A guest editorial from abroad: Medicolegal opinion - Time for peer review. Obstetrical & Gynecological Survey, 56(3), 121-123.
DOI Scopus3 WoS3 Europe PMC3
2001 MacLennan, A. (2001). The ascent of woman. Climacteric, 4(4), 265-266.
DOI
2001 Cabrol, D., Gillett, J., Madelenat, P., Lansac, J., Paniel, B., Dellenbach, P., . . . Permezel, J. (2001). Treatment of preterm labor with the oxytocin antagonist atosiban: a double-bind, randomized, controlled comparison with salbutamol. European Journal of Obstetrics Gynecology and Reproductive Biology, 98(2), 177-185.
DOI Scopus85 WoS65 Europe PMC51
2001 Moutquin, J., Cabrol, D., Fisk, N., MacLennan, A., Marsal, K., & Rabinovici, J. (2001). Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108(2), 133-142.
DOI WoS188
2001 Diamond, T., Sambrook, P., Williamson, M., Flicker, L., Nowson, C., Fiatarone-Singh, M., . . . MacLennan, A. (2001). Men and osteoporosis. Australian Family Physician, 30(8), 781-785.
Scopus6 Europe PMC3
2001 MacLennan, A. (2001). For how long should a woman take hormone replacement therapy?. Middle East Fertility Society Journal, 6(1), 9-12.
2001 Diamond, T., Sambrook, P., Williamson, M., Flicker, L., Nowson, C., Fiatarone-Singh, M., . . . MacLennan, A. (2001). Guidelines for treatment of osteoporosis in men. Australian Family Physician, 30(8), 787-791.
Scopus16 Europe PMC8
2001 Sambrook, P., Diamond, T., Ferris, L., Fiatarone-Singh, M., Flicker, L., MacLennan, A., . . . Greville, H. (2001). Corticosteroid induced osteoporosis. Australian Family Physician, 30(8), 793-796.
2001 MacLennan, A., Lester, S., & Moore, V. (2001). Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric, 4(1), 58-74.
DOI Scopus159 Europe PMC90
2001 Eckert, K., Turnbull, D., & MacLennan, A. (2001). Immersion in water in the first stage of labor: A randomized controlled trial. Birth-issues in Perinatal Care, 28(2), 84-93.
DOI Scopus63 WoS50 Europe PMC50
2001 Spencer, M., & MacLennan, A. (2001). How long does it take to deliver a baby by emergency Caesarean section?. Australian & New Zealand Journal of Obstetrics & Gynaecology, 41(1), 7-11.
DOI Scopus42 WoS38 Europe PMC33
2001 MacLennan, A., Lester, S., & Moore, V. (2001). Oral oestrogen replacement therapy versus placebo for hot flushes.. Cochrane Database of Systematic Reviews Online, (1), CD002978.
DOI Scopus148 Europe PMC25
2001 Eckert, K., Turnbull, D., & MacLennan, A. (2001). Warm water bathing did not reduce use of pharmacological analgesia during the first stage of labour. Evidence Based Medicine, 6(6), 177.
DOI Scopus1
2001 Moutquin, J. M., Cabrol, D., Fisk, N. M., MacLennan, A. H., Maršál, K., & Rabinovici, J. (2001). Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108(2), 133-142.
DOI Scopus257 Europe PMC100
2001 Chui, Y. K., Thijs, I., Bhal, P. S., Spencer, M., & MacLennan, A. (2001). Letter to the editor (multiple letters). Australian and New Zealand Journal of Obstetrics and Gynaecology, 41(3), 355.
2001 MacLennan, A. (2001). Index Medicus and MEDLINE indexing for Climacteric. Climacteric, 4(2), 89-90.
DOI
2001 Sambrook, P. N., Diamond, T., Ferris, L., Fiatarone-Singh, M., Flicker, L., MacLennan, A., . . . Greville, H. (2001). Corticosteroid induced osteoporosis. Guidelines for treatment.. Australian Family Physician, 30(8), 793-796.
Scopus30 Europe PMC13
2000 Sambrook, P., O'Neill, S., Diamond, T., Flicker, L., & MacLennan, A. (2000). Postmenopausal osteoporosis treatment guidelines.. Australian Family Physician, 29(8), 751-758.
DOI Scopus8 Europe PMC3
2000 MacLennan, A. (2000). A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement (Reprinted from British Medical Journal, vol 319, pg 1054-1059, 1999). AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 40(1), 13-21.
WoS14
2000 MacLennan, A. H. (2000). Advertising standards for the complimentary medicines at the climacteric. Climacteric, 3(2), 81-83.
DOI Scopus4 Europe PMC2
2000 MacLennan, A., & Baber, R. (2000). The role of oestrogen in cardiovascular disease: benefit or harm?. Medical Journal of Australia, 172(7), 347-348.
DOI
2000 MacLennan, A. (2000). Establishing probable cause in cerebral palsy - There are problems with the consensus statement - Reply. British Medical Journal, 320(7241), 1076.
DOI Scopus14 Europe PMC5
2000 MacLennan, A. (2000). The descent of woman. Climacteric, 3(4), 225-226.
DOI Scopus8 Europe PMC4
2000 MacLennan, A., Taylor, A., Wilson, D., & Wilson, D. (2000). The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. British Journal of Obstetrics and Gynaecology, 107(12), 1460-1470.
DOI Scopus796 WoS647 Europe PMC529
2000 Spencer, M., Khong, T., Matthews, B., & MacLennan, A. (2000). Haematopoietic indicators of fetal metabolic acidosis. Australian & New Zealand Journal of Obstetrics & Gynaecology, 40(3), 286-289.
DOI Scopus11 WoS9 Europe PMC6
2000 MacLennan, A. (2000). Long-term hormone replacement therapy. Australian Prescriber, 23(5), 90-92.
DOI Scopus6
2000 MacLennan, A., Paine, B., & Marley, J. (2000). WISDOM Will Australian women participate?. Australian Family Physician, 29(8), 797-801.
Scopus3 Europe PMC1
2000 MacLennan, A. (2000). Risk management in cerebral palsy. O &​ G /​ Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2(2), 88-92.
1999 Guthrie, J., Garamszegi, C., Dudley, E., Dennerstein, L., Green, A., MacLennan, A., & Burger, H. (1999). Hormone therapy use in Australian-born women: a longitudinal study. Medical Journal of Australia, 171(7), 358-361.
DOI Scopus6 WoS5 Europe PMC4
1999 MacLennan, A., Wilson, D., & Taylor, A. (1999). Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997. Medical Journal of Australia, 170(11), 524-527.
DOI Scopus15 WoS13 Europe PMC4
1999 MacLennan, A. (1999). A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. British Medical Journal, 319(7216), 1054-1059.
DOI Scopus636 WoS490 Europe PMC370
1999 Nand, S. L., Wren, B. G., Gross, B. A., Heller, G. Z., Webster, M., Baber, R., . . . Wenzel, S. (1999). Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Obstetrics and Gynecology, 93(6), 1009-1013.
DOI Scopus10 Europe PMC2
1999 Maclennan, A. H. (1999). Climacteric news. Climacteric, 2(4), 247.
DOI
1999 MacLennan, A., & Pasternak, J. F. (1999). Acute near-total intrauterine asphyxia. Pediatric Neurology, 20(1), 81-82.
DOI Scopus6 WoS6 Europe PMC2
1999 MacLennan, A. H. (1999). The four harms of harmless therapies: Editorial. Climacteric, 2(2), 73-74.
DOI Scopus15 Europe PMC15
1999 Peverill, R. E., Harper, R. W., MacLennan, A. H., Wilson, D. H., & Taylor, A. W. (1999). Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997 (multiple letters) [1]. Medical Journal of Australia, 171(5), 275.
DOI
1998 Maclennan, A. H. (1998). Happy Birthday, Climacterid. Climacteric, 1(4), 257.
DOI
1998 MacLennan, A. H., & Sturdee, D. W. (1998). The change to Climacteric.. Climacteric : the journal of the International Menopause Society, 1(1), 3-4.
DOI Scopus3 Europe PMC2
1998 MacLennan, A. H. (1998). Cancer, cohorts, confounding and consensus.. Climacteric the Journal of the International Menopause Society, 1(2), 89-90.
DOI Scopus2 Europe PMC2
1998 MacLennan, A. (1998). Editorial: Cancer cohorts, confounding and consensus. Climacteric, 1, 89-90.
1998 MacLennan, A., & Sturdee, D. (1998). Editorial: The change to Climacteric. Climacteric, 1, 3-4.
1998 Farquhar, C., & MacLennan, A. (1998). Where is the evidence for effectiveness of treatments for the menopause? Introducing the Cochrane Collaboration. Climacteric, 1(1), 5-11.
DOI Scopus3 Europe PMC2
1998 MacLennan, A., Wilson, D., & Taylor, A. (1998). Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion. Climacteric, 1(1), 42-49.
DOI Scopus26 Europe PMC18
1998 Wilson, D., Taylor, A., & MacLennan, A. (1998). Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality-of-life dimension. Climacteric, 1(1), 50-54.
DOI Scopus15 Europe PMC10
1998 MacLennan, A. (1998). The management of progestogenic side-effects. Changes / Australasian Menopause Society, 98(2), 5-7.
1998 MacLennan, A. (1998). HRT and breast cancer: is there a link?. Modern Medicine of Australia, 41(9), 17-19.
1998 MacLennan, A. (1998). The Perimenopause - Questions of Management. Current Therapeutics, 39(June), 47-49.
1997 MacLennan, A. (1997). HRT and Breast Cancer. Skeptic, 17, 57-58.
1997 MacLennan, A., & MacLennan, S. (1997). Symptom-giving pelvic girdle relaxation of pregnancy, postnatal pelvic joint syndrome and developmental dysplasia of the hip. Acta Obstetrica et Gynecologica Scandinavica, 76(8), 760-764.
DOI Scopus71 WoS50 Europe PMC39
1997 MacLennan, A. (1997). Osteoporosis. Menopause and beyond.. Australian Family Physician, 26(2), 123-131.
Scopus2 Europe PMC1
1996 Thijssen, J. H. H., & MacLennan, A. H. (1996). Untitled. MATURITAS, 25(2), 85-86.
DOI
1996 Kricker, A., Armstrong, B. K., Prince, R. L., Geelhoed, E. A., Zalcberg, J. R., Siderov, J., . . . Smith, M. (1996). Hormone replacement therapy and breast cancer: What are the facts? [1]. Medical Journal of Australia, 164(6), 379-380.
DOI
1996 MacLennan, A., Wilson, D., & Taylor, A. (1996). The self-reported prevalence of postnatal depression.. The Australian & New Zealand journal of obstetrics & gynaecology, 36(3), 313.
DOI Scopus9 WoS16 Europe PMC11
1996 MacLennan, A., Wilson, D., & Taylor, A. (1996). A statement concerning postnatal depression. The self-reported prevalence of postnatal depression. Australian and New Zealand Journal of Obstetrics and Gynaecology, 36(3), 313.
DOI Scopus25
1996 MacLennan, A. H., & Smith, M. (1996). Hormone replacement therapy and breast cancer: What are the facts? Reply. MEDICAL JOURNAL OF AUSTRALIA, 164(6), 380.
DOI
1996 MacLennan, A., Wilson, D., & Taylor, A. (1996). Prevalence and cost of alternative medicine in Australia. Lancet, 347(9001), 569-573.
DOI Scopus832 WoS676 Europe PMC511
1996 MacLennan, A. (1996). Menstrual irregularity and menopause. Current Therapeutics, 37(7), 33-35.
1996 MacLennan, A. (1996). Pill, patch or pellet! What's new in HRT?. South Australian Medical Review, 9(12), 33-35.
1995 MacLennan, A., Stanley, F., Blair, E., Rice, G., Stone, P., Robinson, J., . . . Kenny, M. (1995). The origins of cerebral palsy - A consensus statement. Medical Journal of Australia, 162(2), 85-90.
DOI Scopus33 WoS32 Europe PMC4
1995 MacLennan, S., MacLennan, A., & Ryan, P. (1995). Colorectal cancer and oestrogen replacement therapy, a meta analysis of the epidemiological studies. Medical Journal of Australia, 162(9), 491-493.
DOI Scopus46 WoS43 Europe PMC15
1995 MacLennan, A., & Smith, M. (1995). Hormone replacement therapy and breast cancer: What are the facts?. Medical Journal of Australia, 163(9), 483-485.
DOI Scopus3 WoS5
1995 MacLennan, A., Taylor, A., & Wilson, D. (1995). Changes in the use of hormone replacement therapy in South Australia. Medical Journal of Australia, 162(8), 420-422.
DOI Scopus30 WoS29 Europe PMC14
1995 MacLennan, A. (1995). Benefits of sustained oestrogen therapy. Current Therapeutics, 36(3), 107.
1995 MacLennan, A., Grant, P., & Bryant-Greenwood, G. (1995). hRLX-1 in vitro response of human and pig myometrium. Journal of Reproductive Medicine, 40(10), 703-706.
Scopus19 WoS19 Europe PMC10
1995 MACLENNAN, A. H., STANLEY, F., BLAIR, E., RICE, G., STONE, P., ROBINSON, J., . . . KENNY, M. (1995). THE ORIGINS OF CEREBRAL-PALSY. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 31(4), 284-289.
1995 MACLENNAN, A., STANLEY, F., BLAIR, E., RICE, G., STONE, P., ROBINSON, J., . . . KENNY, M. (1995). CONSENSUS STATEMENT ON THE ORIGINS OF CEREBRAL-PALSY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 35(2), 126-131.
DOI
1994 MacLennan, A. H., Chan, F. Y., & Eckert, K. (1994). The Safety of Vaginal Prostaglandin F2α for the Stimulation of Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology, 34(2), 154-158.
DOI Scopus3 WoS4 Europe PMC1
1994 Maclennan, A. H., Crowther, C., & Derham, R. (1994). Does the option to ambulate during spontaneous labour confer any advantage or disadvantage?. Journal of Maternal Fetal and Neonatal Medicine, 3(1), 43-48.
DOI Scopus14
1993 MacLennan, A. H. (1993). 12 Running a menopause clinic. Bailliere S Clinical Endocrinology and Metabolism, 7(1), 243-253.
DOI Scopus4 WoS6 Europe PMC1
1993 MacLennan, A. H., Wenzel, S., Chambers, H. M., & Eckert, K. (1993). Continuous low-dose oestrogen and progestogen hormone replacement therapy: A randomised trial. Medical Journal of Australia, 159(2), 102-106.
DOI Scopus58 WoS42 Europe PMC35
1993 Brännström, M., & Maclennan, A. H. (1993). Relaxin induces ovulations in the in-vitro perfused rat ovary. Human Reproduction, 8(7), 1011-1014.
DOI Scopus24 WoS21 Europe PMC15
1993 MacLennan, A. H., & Wilson, D. (1993). The prevalence of hysterectomy in South Australia. Medical Journal of Australia, 158(12), 807-809.
DOI Scopus29 WoS24 Europe PMC19
1993 MacLennan, A. H., MacLennan, A., & Wilson, D. (1993). The prevalence of oestrogen replacement therapy in South Australia. Maturitas, 16(3), 175-183.
DOI Scopus48 WoS41 Europe PMC29
1993 Norman, R. J., McLoughlin, J. W., Borthwick, G. M., Yohkaichiya, T., Matthews, C. D., MacLennan, A. H., & De Kretser, D. M. (1993). Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: Relationship to gonadotropin and steroid profiles. Fertility and Sterility, 59(1), 130-137.
DOI Scopus29 WoS28 Europe PMC14
1993 MacLennan, A. H. (1993). Who will deliver the next generation?. Medical Journal of Australia, 159(4), 261-263.
DOI Scopus10 WoS12 Europe PMC4
1993 Bell, R. J., Permezel, M., MacLennan, A., Hughes, C., Healy, D., & Brennecke, S. (1993). A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening. Obstetrics and Gynecology, 82(3), 328-333.
Scopus58 WoS50 Europe PMC35
1992 MacLennan, A. (1992). Women, cardiovascular disease and hormone replacement therapy. Medical Journal of Australia, 156(2), 77-78.
DOI Scopus4 WoS6 Europe PMC3
1992 MacLennan, A. (1992). Transdermal oestrogen replacement therapy. Medical Journal of Australia, 156(10), 679-680.
DOI Scopus1
1992 MacLennan, A. (1992). Menopause and preventive medicine.. Australian Family Physician, 21(3), 205.
1992 MacLennan, A. H., O'Neill, S., Kirkgard, Y., Wenzel, S., & Chambers, H. M. (1992). Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy. Medical Journal of Australia, 157(3), 167-170.
DOI Scopus17 Europe PMC8
1992 Green, R. C., & MacLennan, A. H. (1992). Telephone Fetal Heart Rate Monitoring in South Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 32(2), 114-117.
DOI Scopus5 WoS5 Europe PMC5
1992 MACLENNAN, A. H., MACLENNAN, A., ONEILL, S., KIRKGARD, Y., WENZEL, S., & CHAMBERS, H. M. (1992). ESTROGEN AND CYCLICAL PROGESTOGEN IN POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY. MEDICAL JOURNAL OF AUSTRALIA, 157(3), 167-170.
DOI WoS11
1991 MacLennan, A. H. (1991). Hormone replacement therapy and the menopause. Medical Journal of Australia, 155(1), 43-44.
DOI Scopus15 WoS12
1991 MACLENNAN, A. H. (1991). HORMONE REPLACEMENT THERAPY AND THE MENOPAUSE - REPLY. MEDICAL JOURNAL OF AUSTRALIA, 155(5), 351.
DOI WoS1
1991 MacLennan, A. H., & Grant, P. (1991). Human relaxin: In vitro response of human and pig myometrium. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 36(9), 630-634.
Scopus27 WoS28 Europe PMC17
1991 MacLennan, A. H. (1991). Hormone replacement therapy and the menopause. Australian Menopause Society.. The Medical journal of Australia, 155(1), 43-44.
Europe PMC4
1991 MacLennan, A. H. (1991). The role of the hormone relaxin in human reproduction and pelvic girdle relaxation. Scandinavian Journal of Rheumatology Supplement, 20(88), 7-15.
Scopus104 WoS72 Europe PMC39
1991 Maclennan, A. H., Grant, P., & Borthwick, A. C. (1991). Relaxin and relaxin c-peptide levels in human reproductive tissues. Reproduction Fertility and Development, 3(5), 577-583.
DOI Scopus16 WoS17 Europe PMC11
1991 Pervan, Z., & MacLennan, A. H. (1991). Hormone replacement therapy and the menopause [12]. Medical Journal of Australia, 155(5), 350-351.
DOI
1991 MacLennan, A. (1991). Genital persuasion: Prostaglandins for the induction of labour. Medical Journal of Australia, 155(1), 5-7.
DOI Scopus2 WoS2 Europe PMC1
1990 Dreosti, I. E., & MacLennan, A. (1990). Maternal plasma zinc levels and first trimester abortion. Early Human Development, 21(2), 141-142.
DOI Scopus7 WoS7 Europe PMC5
1990 MacLennan, A. H., Rodrigues, L. V., Krutli, D. R., & Klomp, A. (1990). Post-operative discomfort after ring or clip tubal ligation - is there any difference and do indomethacin suppositories help?. Contraception, 42(3), 309-313.
DOI Scopus12 WoS10 Europe PMC6
1990 MacLennan, A. H., Green, R. C., Brookes, C., Morris, D., & O'Shea, R. (1990). Routine hospital admission in twin pregnancy between 26 and 30 weeks' gestation. Lancet, 335(8684), 267-269.
DOI Scopus50 WoS35 Europe PMC38
1990 Maclennan, A. H. (1990). Australian clinical trials with prostaglandins E2 and F2α to induce labour. Reproduction Fertility and Development, 2(5), 557-561.
DOI Scopus1 Europe PMC1
1990 MacLennan, A. H. (1990). Perineal pain after childbirth. Medical Journal of Australia, 152(1), 1-2.
DOI Scopus2 WoS6
1990 MaClennan, A. H., Green, R. C., O'shea, R., Brookes, C., & Morris, D. (1990). Routine hospital admission in twin pregnancy between 26 and 30 weeks' gestation. Obstetrical and Gynecological Survey, 45(9), 604-605.
DOI
1989 Pupula, M., & MacLennan, A. H. (1989). Effect of porcine relaxin on spontaneous, oxytocin-driven and prostaglandin-driven pig myometrial activity in vitro. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 34(10), 819-823.
Scopus7 WoS8 Europe PMC3
1989 MacLennan, A., Fraser, I., Jakubowicz, D., Murray‐Arthur, F., Quinn, M., & Trudinger, B. (1989). Labour Induction with Low Dose PGE2 Vaginal Gel: Result of an Australian Multicentre Randomized Trial*. Australian and New Zealand Journal of Obstetrics and Gynaecology, 29(2), 124-128.
DOI Scopus16 WoS14 Europe PMC10
1988 MacLennan, A. H. (1988). Current management of the menopause.. Australian Family Physician, 17(3), 158-169.
Scopus5 Europe PMC1
1988 GREEN, R. C. (1988). The Fetal Heart Response to Static Antenatal Exercises in the Supine Position. Australian Journal of Physiotherapy, 34(1), 3-7.
DOI Scopus10
1987 Stone, B. A., Petrucco, O. M., Seamark, R. F., & MacLennan, A. H. (1987). Concentrations of steroid hormones, and of relaxin, in utero-ovarian venous plasma of periparturient sows. Animal Reproduction Science, 15(3-4), 227-239.
DOI Scopus3 WoS4
1987 MacLennan, A. H. (1987). Oral contraceptives. Current Therapeutics, 28(12), 113-122.
Scopus2
1986 MacLennan, A. (1986). Optimum use of oral contraceptives. Current Therapeutics, 27(9), 37-48.
1986 Maclennan, A. H., Green, R. C., Grant, P., & Nicolson, R. (1986). Ripening of the human cervix and induction of labor with intracervical purified porcine relaxin. Obstetrics and Gynecology, 68(5), 598-601.
Scopus51 Europe PMC28
1986 Maclennan, A., Green, R., Nicolson, R., & Bath, M. (1986). Serum relaxin and pelvic pain of pregnancy. The Lancet, 328(8501), 243-245.
DOI Scopus171 WoS139 Europe PMC101
1986 MacLennan, A. H., Grant, P., Ness, D., & Down, A. (1986). Effect of porcine relaxin and progesterone on rat, pig and human myometrial activity in vitro. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 31(1), 43-49.
Scopus27 WoS35 Europe PMC20
1986 MacLennan, A. H., Rippin, C., & Tiver, J. (1986). Obstetric Team Care by a Private Midwife and Obstetrician—A Pilot Trial. Australian and New Zealand Journal of Obstetrics and Gynaecology, 26(1), 40-44.
DOI Scopus2 Europe PMC1
1986 Maclennan, A., Nicolson, R., & Green, R. (1986). Serum relaxin in pregnancy. The Lancet, 328(8501), 241-243.
DOI Scopus58 WoS61 Europe PMC34
1986 Pupula, M., Quinn, P., & MacLennan, A. (1986). The effect of porcine relaxin on the fertilisation of mouse oocytes in vitro. Clinical Reproduction and Fertility, 4(6), 383-387.
Scopus17 Europe PMC6
1985 MacLennan, A. H., Katz, M., & Creasy, R. (1985). The morphologic characteristics of cervical ripening induced by the hormones relaxin and prostaglandin F2α in a rabbit model. American Journal of Obstetrics and Gynecology, 152(6), 691-696.
DOI Scopus13 Europe PMC6
1985 Day, A., MacLennan, A., & Green, R. (1985). A Comparison of Intravaginal PGF2α and Intravenous Oxytocin to Stimulate Labour after Membrane Rupture. Australian and New Zealand Journal of Obstetrics and Gynaecology, 25(4), 252-255.
DOI Scopus9 Europe PMC7
1985 MacLennan, A. H., Kerin, J. F. P., Kirby, C., Grant, P., Warnes, G. M., Cox, L. W., . . . Greenwood, F. (1985). The Effect of Porcine Relaxin Vaginally Applied at Human Embryo Transfer in an In Vitro Fertilization Programme. Australian and New Zealand Journal of Obstetrics and Gynaecology, 25(1), 68-71.
DOI Scopus7 Europe PMC5
1984 Cheek, D. B., Wishart, J., MacLennan, A. H., & Haslam, R. (1984). Cell hydration in the normally grown, the premature and the low weight for gestational age infant. Early Human Development, 10(1-2), 75-84.
DOI Scopus31 WoS30 Europe PMC14
1984 LUKACS, H. A., MacLENNAN, A. H., & VERCO, P. W. (1984). Ultrasonic fetal weight estimation in multiple and singleton pregnancy. Journal of Paediatrics and Child Health, 20(1), 59-61.
DOI Scopus1 WoS2 Europe PMC1
1984 CHEEK, D. B., WISHART, J., MACLENNAN, A., & HASLAM, R. (1984). HYDRATION IN THE NEONATE DYSMATURE PREMATURE. AUSTRALIAN PAEDIATRIC JOURNAL, 20(4), 342.
1983 Rogers, P. A. W., Murphy, C. R., Squires, K. R., & MacLennan, A. H. (1983). Effects of relaxin on the intrauterine distribution and antimesometrial positioning and orientation of rat blastocysts before implantation. Journal of Reproduction and Fertility, 68(2), 431-435.
DOI Scopus29 WoS30 Europe PMC15
1983 MacLennan, A. H., Hocking, A., Seamark, R. F., Godfrey, B., & Haslam, R. (1983). Neonatal water metabolism: an objective postnatal index of intrauterine fetal growth. Early Human Development, 8(1), 21-31.
DOI Scopus7 WoS5 Europe PMC1
1983 MacLennan, A. H. (1983). The role of relaxin in human reproduction. Clinical Reproduction and Fertility, 2(2), 77-95.
Scopus28 Europe PMC18
1982 Cheek, D. B., Wishart, J., MacLennan, A. H., Haslam, R., & Fitzgerald, A. (1982). Hydration in the first 24 h of postnatal life in normal infants born vaginally or by caesarean section. Early Human Development, 7(4), 323-330.
DOI Scopus21 WoS19 Europe PMC10
1982 Cooper, E., Anderson, A., Bennett, M. J., MacLennan, A. H., Stirrat, G. M., & Burke, C. W. (1982). Radioimmunoassay of thyroxine and 3,3',5'-triiodothyronine (reverse T3) in human amniotic fluid. Clinica Chimica Acta, 118(1), 57-66.
DOI Scopus9 WoS8 Europe PMC3
1982 Burgoyne, J. L., Ballard, F. J., Tomas, F. M., Dobozy, A., MacLennan, A. H., Fitzgerald, A., & Dahlenburg, G. W. (1982). Measurements of myofibrillar protein breakdown in newborn human infants. Clinical Science, 63(5), 421-427.
DOI Scopus11 WoS15 Europe PMC8
1981 MacLennan, A. H. (1981). Relaxin – A Review. Australian and New Zealand Journal of Obstetrics and Gynaecology, 21(4), 195-202.
DOI Scopus18 WoS20 Europe PMC10
1981 MacLennan, A. H., Green, R. C., Bryant-Greenwood, G. D., Greenwood, F. C., & Seamark, R. F. (1981). Cervical ripening with combinations of vaginal prostaglandin F2αestradiol, and relaxin. Obstetrics and Gynecology, 58(5), 601-604.
Scopus28 WoS29 Europe PMC14
1981 MacLennan, A. H., Millington, G., Grieve, A., McIntosh, J. E. A., Seamark, R. F., & Cox, L. W. (1981). Neonatal body water turnover: A putative index of perinatal morbidity. American Journal of Obstetrics and Gynecology, 139(8), 948-952.
DOI Scopus7 WoS7 Europe PMC3
1980 MacLennan, A. (1980). Pill prescription by potency: A simplified method of oral contraceptive selection. Current Therapeutics, 21(7), 45-50.
1980 MacLennan, A. (1980). Management of the hypertensive crisis in pregnancy. Current Therapeutics, 21(11), 63-73.
1980 MacLennan, A. (1980). Hormone replacement therapy: More facts and less fear. Current Therapeutics, 21(8), 11-15.
1980 MacLennan, A. H., & Green, R. C. (1980). The Effect of Intravaginal Prostaglandin F2α on Labour after Spontaneous and Artificial Rupture of the Membranes. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(2), 87-90.
DOI Scopus14 WoS13 Europe PMC7
1980 Finikiotis, G., MacLennan, A. H., Verco, P. W., & Ogden, S. E. (1980). An Evaluation of Two Methods of Antenatal Ultrasonic Fetal Weight Estimation. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(3), 135-138.
DOI Scopus10 WoS9 Europe PMC1
1980 Maclennan, A. H., Green, R. C., Bryant-Greenwood, G. D., Greenwood, F. C., & Seamark, R. F. (1980). RIPENING OF THE HUMAN CERVIX AND INDUCTION OF LABOUR WITH PURIFIED PORCINE RELAXIN. Lancet, 315(8162), 220-223.
DOI Scopus77 WoS100 Europe PMC35
1980 MaeLennan, A. H., & Green, R. C. (1980). A Double Blind Dose Trial of Intravaginal Prostaglandin F2α for Cervical Ripening and the Induction of Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology, 20(2), 80-83.
DOI Scopus15 WoS11 Europe PMC11
1980 FINIKIOTIS, G., MACLENNAN, A. H., VERCO, P. W., & OGDEN, S. E. (1980). ANTENATAL FETAL WEIGHT ESTIMATION BY ULTRASONOGRAPHY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 20(3), 193.
1979 MACLENNAN, A. H., SEAMARK, R. F., GRIEVE, A. W., BRAYBROOK, R. C., & HENDERSON, C. (1979). NEONATAL BODY-WATER TURNOVER AS AN INDEX OF FETAL MORBIDITY. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 19(3), 180.
1979 MacLennan, A. H., & Green, R. C. (1979). Fetal Heart Rate Monitoring During Ambulant Labour Using a Modified Adult Radiotelemetry System. Australian and New Zealand Journal of Obstetrics and Gynaecology, 19(3), 135-138.
DOI Scopus2 WoS5 Europe PMC1
1979 MACLENNAN, A. H., & GREEN, R. C. (1979). INTERVENTION IN LABOR WITHOUT INTERFERENCE - RADIOTELEMETRY AND VAGINAL PROSTAGLANDINS. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 19(3), 180-181.
1979 Maclennan, A. H., & Green, R. C. (1979). CERVICAL RIPENING AND INDUCTION OF LABOUR WITH INTRAVAGINAL PROSTAGLANDIN F2α. Lancet, 313(8108), 117-119.
DOI Scopus30 WoS25 Europe PMC21
1978 MACLENNAN, A. H. (1978). AUDIT OF OBSTETRIC PRACTICE IN MANAGEMENT OF LABOR. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 18(4), 287-288.
WoS1
1977 Cooper, E., Manning, D. M., MacLennan, A. H., & Burke, C. W. (1977). Thyroid hormones in human amniotic fluid: detection of tri-iodothyronine and free levels of thyroxine, tri-iodothyronine and 3,3',5'-tri-iodothyronine [proceedings]. Journal of Endocrinology, 73(3), 44.
Scopus5 WoS7 Europe PMC2
1977 Hoult, I. J., Maclennan, A. H., & Carrie, L. E. S. (1977). Lumbar epidural analgesia in labour: Relation to fetal malposition and instrumental delivery. British Medical Journal, 1(6052), 14-16.
DOI Scopus130 WoS130 Europe PMC76
1976 MacLennan, A. H., Emerson, P. M., Hunter, D. J. S., & Darley, J. H. (1976). Tissue oxygenation and red cell 2,3-diphosphoglycerate in normal and abnormal pregnancy. British Journal of Obstetrics and Gynaecology, 83(5), 378-382.
DOI Scopus9 WoS9 Europe PMC6
1976 Sklovsky, E., & MacLennan, A. H. (1976). Reliable detection of ruptured membranes. British Medical Journal, 2(6042), 1014.
DOI Scopus2 WoS2 Europe PMC2
1975 MacLennan, A. H., Carty, M. J., Sheppard, B. L., & Sharp, F. (1975). An ultrastructural study of the reversibility of the effects of hypoxia on human trophoblast maintained in organ culture. Journal of Reproduction and Fertility, 43(3), 501-504.
DOI Scopus3 WoS3 Europe PMC3
1975 MacLennan, A. H., Roxburgh, D., Thornton, C., Knightley, M., & Moore, R. A. (1975). PALMITIC ACID LEVELS IN AMNIOTIC FLUID AND THE SHAKE TEST. BJOG: An International Journal of Obstetrics & Gynaecology, 82(3), 199-203.
DOI Scopus2 WoS5
1975 Moore, R. A., O'Neil, K. T. J., Cooke, R. J., & MacLennan, A. H. (1975). PALMITIC ACID AND LECITHIN MEASUREMENTS IN AMNIOTIC FLUID. BJOG an International Journal of Obstetrics Gynaecology, 82(3), 194-198.
DOI Scopus12 WoS18 Europe PMC4
1972 MacLennan, A. H., Sharp, F., & Shaw-Dunn, J. (1972). The ultrastructure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture. A comparison with uultrastructural changes in pre-eclampsia and placental insufficiency.. Journal of Obstetrics and Gynaecology of the British Commonwealth, 79(2), 113-121.
DOI Scopus16 Europe PMC10
1972 MacLennan, A. H., Sharp, F., & Shaw‐Dunn, J. (1972). THE ULTRASTRUCTURE OF HUMAN TROPHOBLAST IN SPONTANEOUS AND INDUCED HYPOXIA USING A SYSTEM OF ORGAN CULTURE: A Comparison with Ultrastructural Changes in Pre‐eclampsia and Placental Insufficiency. BJOG an International Journal of Obstetrics Gynaecology, 79(2), 113-121.
DOI Scopus47 Europe PMC17
1971 Wynn, R. M., Panigel, M., & MacLennan, A. H. (1971). Fine structure of the placenta and fetal membranes of the baboon. American Journal of Obstetrics and Gynecology, 109(4), 638-648.
DOI Scopus29 Europe PMC21
1971 Maclennan, A. H., & Wynn, R. M. (1971). Menstrual cycle of the baboon: I. clinical features, vaginal cytology and endometrial histology. Obstetrics and Gynecology, 38(3), 350.
Scopus20 Europe PMC12
1971 MaClennan, A. H., Harris, J. A., & Wynn, R. M. (1971). Menstrual cycle of the baboon: II. endometrial ultrastructure. Obstetrics and Gynecology, 38(3), 359.
Scopus16 Europe PMC15
1971 French, G. L., MacLennan, A. H., & Wynn, R. M. (1971). Nucleoside phosphatases in human amnion ultrastructural localization. Obstetrics and Gynecology, 37(2), 173-182.
Scopus3 Europe PMC3
1961 MACLENNAN, A. H. (1961). Fetal loss in cesarean section. American Journal of Obstetrics and Gynecology, 82(1), 22-26.
DOI Scopus1 Europe PMC2

Year Citation
2018 van Eyk, C., Corbett, M., & Maclennan, A. (2018). The emerging genetic landscape of cerebral palsy.. In D. H. Geschwind, H. L. Paulson, & C. Klein (Eds.), Neurogenetics (Vol. 147, pp. 331-342). Elsevier.
DOI Scopus27 Europe PMC15
2001 MacLennan, A. (2001). Pelvic girdle relaxation, developmental dysplasia of the hip and the hormone relaxin - are they loosely connected?. In G. Tregear, R. Ivell, R. Bathgate, & J. Wade (Eds.), RELAXIN 2000 - Proceedings of the Third International Conference on Relaxin & Related Peptides (pp. 407-413). PO Box 17, 3300 AA Dordrecht, Netherlands: Kluwer Academic Publishers.
WoS2
1997 MacLennan, A. (1997). What measures should we adopt to improve hormone replacement therapy compliance during the next decade?. In Progress in the management of the menopause (pp. 446-451). The Parthenon Publishing Group.
WoS1
1997 MacLennan, A. (1997). Sexuality and the menopause. In Sex in long-term relationships (pp. 19-23). Allen and Unwin.
1996 MacLennan, A. (1996). Symptoms and signs of the climacteric. In Clinical management of the menopause (pp. 7-15). McGraw-Hill Book.
1995 MacLennan, A. (1995). The effect of relaxins on myometrial activity and cervical ripening. In Progress in Relaxin Research (pp. 263-288). Global Publications.
WoS4
1995 Borthwick, A., Borthwick, G., Grant, P., & MacLennan, A. (1995). Relaxin levels in the human: An indicator of target, storage and production sites. In Progress in Relaxin Research (pp. 251-260). Global Publications.
WoS8
1995 Borthwick, A., Borthwick, G., & MacLennan, A. (1995). Binding of phospho-relaxin and biotinylated relaxin to porcine and human reproductive tissues. In Progress in Relaxin Research (pp. 315-324). Global Publications.
WoS1
1995 Bell, R., Permezel, M., & MacLennan, A. (1995). Clinical trials of cervical ripening with human relaxin. In Progress in Relaxin Research (pp. 350-378). Global Publications.
WoS3

Year Citation
2022 van Eyk, C. L., Webber, D. L., Minoche, A., Perez-Jurado, L., Corbett, M., Gardner, A., . . . Gecz, J. (2022). Yield of clinically reportable genetic variants in cerebral palsy by whole genome sequencing. In EUROPEAN JOURNAL OF HUMAN GENETICS Vol. 30 (pp. 59). SPRINGERNATURE.
2010 O'Callaghan, M. E., MacLennan, A. H., Goldwater, P. N., McMichael, G., & et al. (2010). Australian Collaborative Study of genomic and environmental factors associated with CP. In Conference Proceedings. Sydney, Australia.
2010 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et al. (2010). Apolipoprotein E genotype is not associated with CP. In Developmental Medicine and Child Neurology. Sydney, Australia: Mac Keith Press.
2008 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et al.,. (2008). Stored cord serum: is it an additional resource for research into fetal viral exposure?. In Australian Society for Medical Research Conference, SA Branch. Adelaide, Australia.
2008 McMichael, G. L., Gibson, C. S., MacLennan, A. H., & et.al.,. (2008). Stored cord serum: is it an additional resource for research into fetal viral exposure?. In Perinatal Society of Australia and New Zealand 12th Annual Congress. Gold Coast, Australia.
2005 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2005). The association between inherited cytokine polymorphisms and cerebral palsy. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S2). Miami Beach, FL: MOSBY, INC.
DOI
2005 Gibson, C., Janssen, N., Kisi, W., MaClennan, A., Hague, B., Haan, E., . . . Dekker, G. (2005). The role of fetal inherited thrombophilia in the development of adverse pregnancy outcomes. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S14). Miami Beach, FL: MOSBY, INC.
DOI
2005 Gibson, C., MacLennan, A., Goldwater, P., Haan, E., Priest, K., & Dekker, G. (2005). The role of fetal viral infection in the development of adverse pregnancy outcomes. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 193 (pp. S188). Miami Beach, FL: MOSBY, INC.
DOI
2003 Gibson, C., Maclennan, A., Hague, B., Rudzki, Z., Sharpe, P., Chan, A., & Dekker, G. (2003). Fetal thrombophilic polymorphisms are not a risk factor for cerebral palsy. In AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Vol. 189 (pp. S75). NEW ORLEANS, LOUISIANA: MOSBY, INC.
DOI WoS3
2000 MacLennan, A. (2000). A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement. International Cerebral Palsy Task Force.. In Australian New Zealand Journal of Obstetrics Gynaecology Vol. 40 (pp. 13-21). Australia: Wiley.
DOI Scopus17 Europe PMC12
1997 MacLennan, A. (1997). The general practitioner's perspective on the management of osteoporosis. In Australian Prescriber Vol. 20 (pp. 67-69).
1990 MACLENNAN, A. H. (1990). AUSTRALIAN CLINICAL-TRIALS WITH PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F2-ALPHA TO INDUCE LABOR. In REPRODUCTION FERTILITY AND DEVELOPMENT Vol. 2 (pp. 557-561). MONASH MED CTR, MELBOURNE, AUSTRALIA: C S I R O PUBLICATIONS.
DOI WoS3

Year Citation
1994 Authors: MacLennan A. Title: Editorial. Description: N/A. Extent: N/A.
DOI

Year Citation
2007 Authors: MacLennan A. Title: International Menopause Society Recommendations on Postmenopausal Hormone Therapy. Description: N/A. Extent: N/A.
Grants and Funding
Research Grants
2011-2013

Cerebral Palsy Institute/Foundation, NSW

Special Initiative and infrastructure Grant

600,000
2011-2014 Australian Commonwealth “Health Workforce Australia” Grant for the establishment of a Women’s Health Teaching Clinic 860,000
2012-2014

NHMRC Project Grant

Copy Number Variations in Cerebral palsy

 640,000
2012-2013

Brain Foundation

The contribution of inflammatory mediators to cerebral palsy

 39,000
2012-2013

Robinson Institute Research Grant

The Genomics of Cerebral Palsy

 34,000
2014-2015

Research Foundation of Cerebral Palsy Alliance

Defining the Role of genetic variations in cerebral palsy causation

 300,000
2014-2017

Research Foundation of Cerebral Palsy Alliance

Tenix Adelaide cerebral palsy research group infrastructure grant

800,000
2014

Rebecca L Cooper Medical Research Foundation Equipment Grant

For data storage and analysis at Genetic Repositories Australia

 22,000
2016-2019

NHMRC Project Grant

Genetic Pathways to Cerebral Palsy

 1302,000
2016 School of Medicine Equipment Grant  for an integrated Maxwell 16 Nucleic Acid Purification Platform 30,000
2017-2018

Cerebral Palsy Foundation Research Grant

Multi-omics investigations of cerebral palsy causation in discordant monozygotic twins and singletons.

 233,000
2018-2021 Tenix Foundation Infrastructure Grant for the Australian Cerebral Palsy Research Group led by Professor MacLennan 900,000

 

Teaching Experience

I have been a University Lecturer, Senior Lecturer, Reader or Associate Professor since 1973 and have been actively involved in undergraduate, postgraduate and midwifery teaching programmes.  I have also been involved in the examination of these three groups of students.  I have been a supervisor for PhD and MSc students, an external postgraduate examiner for Melbourne University, Sydney University, the Australian Medical Council, The Royal College of Midwives, Australian College of Physiotherapists and the Supervisor of Trainees for the Royal Australian College of Obstetricians and Gynaecologists.  I enjoy teaching and am regularly involved in giving lectures by invitation to my peers at international and national College, Hospital and University meetings. 

Educational Videos

I have been particularly involved in the development of video programmes for student and patient education.  I have helped establish the Education Resource Centre at The Queen Victoria Hospital, Adelaide and have been involved in the production and direction of more than 35 video presentations for undergraduates, postgraduates, health personnel and the lay public.  Some of these videos are now being distributed internationally (see list at end of publications). 

On behalf of Adelaide University I have run 3 courses for gifted children entitled New Horizons in Reproductive Medicine.

In recent years I have been involved in changing our undergraduate curriculum from lecture-based to problem solving format with increasing clinical contact.  I have helped develop new methods of student examination, including oral structured clinical examinations.

Date Role Research Topic Program Degree Type Student Load Student Name
2010 - 2012 Principal Supervisor The Genomics of Cerebal Palsy Are Copy Number Variants Associated with Cerebal Palsy? Master of Philosophy (Medical Science) Master Full Time Dr Gai McMichael
2010 - 2011 Principal Supervisor The Australian Cerebral Palsy Research Study ¿ Epidemiological & Genetic Associations with Cerebral Palsy Doctor of Philosophy Doctorate Full Time APrf Michael O'Callaghan
2003 - 2005 Principal Supervisor Antenatal Causes of Cerebral Palsy and Adverse Pregnancy Outcomes: Investigating Associations between Inherited Thrombophilia, Cytokine Polymorphisms and Viral Infections Doctor of Philosophy Doctorate Full Time Dr Catherine Gibson

Connect With Me

External Profiles

Other Links